The Role of L3T4 in T Cell Activation: L3T4 May Be Both an Ia-binding Protein and a Receptor That Transduces a Negative Signal
Overview
Authors
Affiliations
The T cell surface molecules Lyt-2 and L3T4 are strongly correlated with the class of MHC gene product recognized by the T cell bearing them. The L3T4 molecule has been proposed to play a role in enhancing recognition of antigen:Ia by specific T cells. In the present experiments, we have explored the role of L3T4 in T cell activation by examining the effects of the L3T4-specific monoclonal antibody GK1.5 on T cell responses in the presence or absence of class II-MHC gene products. Our studies show that GK1.5 inhibits T cell activation in the absence of class II-MHC gene products, while antibodies to other T cell surface molecules do not transduce negative signals to the same cells. We interpret our results as suggesting a signaling role for L3T4 and, by inference, for Lyt-2 as well. We would propose that L3T4 molecules on the class II-restricted T cell initiate the interaction between the L3T4+ T cell and its class II-MHC gene product bearing target cell (B cell, APC). This initial contact is important in allowing a finite time for antigen, Ia, and the T cell receptor to form an activating complex, which in turn transduces a dominant on signal to the cell. In the absence of specific antigen, or if the class II-bearing cell is of the wrong MHC genotype, so that the antigen:Ia receptor is not aggregated, then the association of L3T4 with class II molecules transduces a net negative signal to the T cell. We suggest that this negative signal is responsible for T cell:target cell deconjugation under these circumstances. Thus, we would propose that L3T4 initiates T cell:Ia-bearing cell interactions and, a finite time later, signals the T cell to discontinue the interaction unless a stimulating level of the antigen:Ia complexes for which the T cell's receptor is specific is present.
Basophils initiate IL-4 production during a memory T-dependent response.
Khodoun M, Orekhova T, Potter C, Morris S, Finkelman F J Exp Med. 2004; 200(7):857-70.
PMID: 15466620 PMC: 2213291. DOI: 10.1084/jem.20040598.
Brett S, Rowan W, Smith M, Bartholomew M, Tite J Immunology. 1997; 91(3):346-53.
PMID: 9301522 PMC: 1364002. DOI: 10.1046/j.1365-2567.1997.00265.x.
Madrenas J, Chau L, Smith J, Bluestone J, Germain R J Exp Med. 1997; 185(2):219-29.
PMID: 9016871 PMC: 2196122. DOI: 10.1084/jem.185.2.219.
The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling.
Racioppi L, Matarese G, DOro U, De Pascale M, Masci A, Fontana S Proc Natl Acad Sci U S A. 1996; 93(19):10360-5.
PMID: 8816805 PMC: 38389. DOI: 10.1073/pnas.93.19.10360.
Partial signaling by CD8+ T cells in response to antagonist ligands.
Reis e Sousa C, LEVINE E, Germain R J Exp Med. 1996; 184(1):149-57.
PMID: 8691128 PMC: 2192672. DOI: 10.1084/jem.184.1.149.